logo

For the Inventor, By the Inventor

Lane Cove, Australia

Adrian Lee

This inventor holds 9 USPTO granted patents. Top assignees: Csl Limited, The University of New South Wales, Massachusetts Institute of Technology. Active years: 1999-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adrian Lee. Retrieved from https://idiyas.com/inventor/adrian-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 100.0

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 18(Granted Patents)


Company Filing History:

goldMedal4 out of 123 
 
Csl Limited
 patents
silverMedal3 out of 10 
 
The University of New South Wales
 patents
bronzeMedal1 out of 8,583 
 
Massachusetts Institute of Technology
 patents
4. 4 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1999-2004

Loading Chart...
9 patents (USPTO):Explore Patents
1. 6762295 - Protective helicobacter antigens (2004-07-13),
2. 6663873 - Antigenic preparation for treatment or prevention of helicobacter infection (2003-12-16),
3. 6630582 - Treatment and prevention of helicobacter infection (2003-10-07),
4. 6599509 - Compositions and methods comprising helicobacter antigens for treatment and prevention of inflammatory bowel disease (2003-07-29),
5. 6468545 - Treatment and prevention of helicobacter infection (2002-10-22),
6. 6406703 - Treatment of H. pylori associated gastroduodenal disease (2002-06-18),
7. 6129923 - Treatment of H. pylori associated gastroduodenal disease (2000-10-10),
8. 6005090 - Treatment and prevention of helicobacter infection (1999-12-21),
9. 5871749 - Therapeutic treatment of H. pylori associated gastroduodenal disease (1999-02-16),

Title: The Innovations of Adrian Lee

Introduction

Adrian Lee is a notable inventor based in Lane Cove, Australia. He has made significant contributions to the field of medical science, particularly in the area of Helicobacter research. With a total of 9 patents to his name, Lee's work has the potential to impact the treatment and prevention of gastroduodenal diseases.

Latest Patents

Among his latest patents, Lee has developed protective Helicobacter antigens, specifically targeting H. pylori antigens. These innovations focus on the treatment and prevention of gastroduodenal diseases associated with H. pylori infection. Another significant patent is an antigenic preparation designed for the treatment or prevention of Helicobacter infection in mammalian hosts. This preparation comprises the lipopolysaccharide (LPS) of Helicobacter bacteria, particularly the LPS of H. pylori, or an immunogenic fragment thereof.

Career Highlights

Throughout his career, Adrian Lee has worked with various organizations, including CSL Limited. His research and inventions have contributed to advancements in medical treatments and have garnered attention in the scientific community.

Collaborations

Lee has collaborated with notable individuals in his field, including Christopher Vincent Doidge and Stuart L Hazell. These partnerships have further enhanced his research and innovation efforts.

Conclusion

Adrian Lee's contributions to the field of medical science through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in the treatment of Helicobacter infections and related diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…